Literature DB >> 15136881

Acute respiratory failure in a patient with sarcoidosis and immunodeficiency--an unusual presentation and a complicated course.

Adi Leiba1, Sara Apter, Merav Leiba, Michael Thaler, Ehud Grossman.   

Abstract

Pulmonary sarcoidosis is usually a chronic, insidious disease resulting from granuloma formation in the lung parenchyma. The epithelioid non-caseating granulomata of sarcoidosis are the result of a T-helper1-mediated immune reaction to an unknown self or foreign antigen. We describe the case of a patient with sarcoidosis and a coexistent common variable immunodeficiency who presented with rapidly progressive respiratory failure. This unusual presentation was followed by a complicated course with recurrent pneumoccocal infections, which could be explained by the coexistence of common variable immunodeficiency. Physicians should be alert to the possibility of sarcoidosis even when the clinical presentation is of acute respiratory distress syndrome (ARDS) since early treatment with steroids can be lifesaving. The detection of accompanying hypogammaglobulinemia is also crucial, as treatment with intravenous immunoglobulins (IVIG) together with steroids can improve the patient's outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136881     DOI: 10.1007/s00408-003-1045-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  10 in total

1.  ["Sarcoidosis-like" granulomatous disease in patients with common variable hypogammaglobulinemia].

Authors:  Andrea Matucci; Oliviero Rossi; Lorenzo Cecchi; Alessandra Vultaggio; Serena Checcacci; Paola Parronchi; Lorenzo Emmi; Enrico Maggi; Sergio Romagnani
Journal:  Ann Ital Med Int       Date:  2002 Apr-Jun

Review 2.  Speculations on sarcoidosis.

Authors:  C M O'Connor; M X FitzGerald
Journal:  Respir Med       Date:  1992-07       Impact factor: 3.415

3.  Granulomatous disease in common variable immunodeficiency.

Authors:  L J Mechanic; S Dikman; C Cunningham-Rundles
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

4.  Sarcoidosis and common variable immunodeficiency. A case of a malignant course of sarcoidosis in conjunction with severe impairment of the cellular and humoral immune system.

Authors:  G Sutor; H Fabel
Journal:  Respiration       Date:  2000       Impact factor: 3.580

Review 5.  The primary immunodeficiencies.

Authors:  F S Rosen; M D Cooper; R J Wedgwood
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

Review 6.  Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

Authors:  M B Fasano; K E Sullivan; S B Sarpong; R A Wood; S M Jones; C J Johns; H M Lederman; M J Bykowsky; J M Greene; J A Winkelstein
Journal:  Medicine (Baltimore)       Date:  1996-09       Impact factor: 1.889

7.  Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features.

Authors:  J J Wright; D K Wagner; R M Blaese; C Hagengruber; T A Waldmann; T A Fleisher
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

8.  Hypogammaglobulinemia and rheumatic disease.

Authors:  A H Lee; A I Levinson; H R Schumacher
Journal:  Semin Arthritis Rheum       Date:  1993-02       Impact factor: 5.532

9.  Pulmonary sarcoidosis and the acute respiratory distress syndrome (ARDS).

Authors:  F Sabbagh; C Gibbs; L S Efferen
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

10.  Selective IgA deficiency associated with recurrent sinopulmonary infections in sarcoidosis.

Authors:  I Rubinstein; G L Baum
Journal:  Eur J Respir Dis       Date:  1984-10
  10 in total
  3 in total

1.  Acute alveolar sarcoidosis presenting with hypoxaemic respiratory failure.

Authors:  Kamal Gera; Nitesh Gupta; Anuradha Ahuja; Ashok Shah
Journal:  BMJ Case Rep       Date:  2014-04-30

Review 2.  An update on interventional lung assist devices and their role in acute respiratory distress syndrome.

Authors:  Marc-Alexander von Mach; Joachim Kaes; Babatunde Omogbehin; Ingo Sagoschen; Jascha Wiechelt; Kristina Kaiser; Oliver Sauer; Ludwig Sacha Weilemann
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

3.  What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.

Authors:  Astrid C van Stigt; Willem A Dik; Lieke S J Kamphuis; Bas M Smits; Joris M van Montfrans; P Martin van Hagen; Virgil A S H Dalm; Hanna IJspeert
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.